Aimei Health Technology Co Ltd's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Aimei Health Technology Co Ltd (AFJK) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
API endpoints for this dataset
Aimei Health Technology Co Ltd's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Aimei Health Technology Co Ltd | - | - | - | Yes |
| Competitors combined (2) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
AFJK Stock Performance relative to its Competitors
Aimei Health Technology Co Ltd's Comment on Competition and Industry Peers
Publicly Traded Peers of Aimei Health Technology Co Ltd
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Aimei Health Technology Co Ltd |
- | - |
 Equity Residential |
24,437.67 | 3,030.82 |
 Strategic Acquisitions Inc |
17.74 | 0.08 |
| SUBTOTAL | 24,455.42 | 3,030.90 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Aimei Health Technology Co Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Aimei Health Technology Co Ltd's Competitors Named by the Company
Competitive relationships identified from Aimei Health Technology Co Ltd reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Strategic Acquisitions Inc | Company report | 85% |
| Equity Residential | Company report | 85% |
Company report basis, confidence, active dates and source counts for Aimei Health Technology Co Ltd's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Aimei Health Technology Co Ltd's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Aimei Health Technology Co Ltd | - | - | - |
| Equity Residential | 24,438 | 1,894,260 | 562,004 |
| Strategic Acquisitions Inc | 18 | 42,456 | -37,956 |
| PEERS TOTAL | 24,455 | 1,891,948 | 561,255 |
Aimei Health Technology Co Ltd's Position in Industry Market Structure
Market-capitalization share and concentration across all 175 companies in Aimei Health Technology Co Ltd's industry classification, broader than the peer set above. Market cap in millions of $.Aimei Health Technology Co Ltd ranks #0 of 175 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 120, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Dutch Oven Gold Group Inc | 1,700 | 5.79 % |
| 2 | Jaws Mustang Acquisition Corporation | 940 | 3.20 % |
| 3 | Constellation Acquisition Corp I | 677 | 2.30 % |
| 4 | Drugs Made In America Acquisition Ii Corp | 513 | 1.75 % |
| 5 | Cantor Equity Partners Iv Inc | 1,234 | 5.2% |
| 6 | Mntn Inc | 1,234 | 5.2% |
| 7 | Gores Holdings X Inc | 1,234 | 5.2% |
| 8 | Aldel Financial Ii inc | 1,234 | 5.2% |
| 9 | American Exceptionalism Acquisition Corp A | 1,234 | 5.2% |
| 10 | Crane Harbor Acquisition Corp Ii | 1,234 | 5.2% |
| 0 | Aimei Health Technology Co Ltd | 76 | 0.00 % |
Market cap and industry share for the rest of Aimei Health Technology Co Ltd's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Aimei Health Technology Co Ltd's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | - | - | - |
| Operating Margin | - | - | - |
| Return on Invested Capital | - | - | -2.72 % |
| P/E | - | 35.9x | 102.1x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Aimei Health Technology Co Ltd's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 120 (see Industry Market Structure & Concentration above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Aimei Health Technology Co Ltd's dedicated Suppliers and Customers pages, not here.
Aimei Health Technology Co Ltd's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- Industry revenue growing at a healthy 26.9% median pace.
- A meaningful share of competitors (50.00 %) show financial-distress signals, a possible opening to gain share.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-9.4% annualized).
Methodology: see Methodology: SWOT Analysis.
Aimei Health Technology Co Ltd's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Aimei Health Technology Co Ltd | 0.00 | 0.01 | - |
| Equity Residential | 0.08 | 0.08 | 0.42 |
| Strategic Acquisitions Inc | 5.55 | 7.82 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Aimei Health Technology Co Ltd's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Aimei Health Technology Co Ltd | Q2 2026 | - | - |
| Equity Residential | Q2 2026 | -10.7 % | -40.8 % |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
| PEERS TOTAL | -10.7 % | -40.9 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Aimei Health Technology Co Ltd's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Aimei Health Technology Co Ltd | Q2 2026 | - | - |
| Equity Residential | Q2 2026 | +4.8 % | -80.8 % |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
Aimei Health Technology Co Ltd's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Aimei Health Technology Co Ltd | 2.00% | 2.39% | - |
| Equity Residential | 4.35% | 3.91% | 8.16% |
| Strategic Acquisitions Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Aimei Health Technology Co Ltd's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Aimei Health Technology Co Ltd | 63.45 | - |
| Equity Residential | 27.68 | 8.06 |
| Strategic Acquisitions Inc | - | 208.97 |
| PEERS AVERAGE | 27.19 | 8.07 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.